Prostaglandin-oxytocin enhancement and potentiation and their clinical applications.
The pharmacological phenomena of enhancement and potentiation of uterine response occur respectively when combinations of some prostaglandins and oxytocin are given serially and simultaneously to a patient. Employing these phenomena allows small doses of the drugs to achieve the same effects as a large dose given alone. In a pilot study of the use of the combination of prostaglandin and oxytocin for the induction of mid-trimester abortion seven of nine women were aborted within 48 hours. Side effects attributable to prostaglandin were eliminated or reduced in severity.
D000028:Abortion, Induced; D000293:Adolescent; D000328:Adult; D000650:Amnion / Q000502:physiology; D004357:Drug Synergism; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D008365:Manometry; D010121:Oxytocin / Q000008:administration & dosage*; D011247:Pregnancy; D011453:Prostaglandins / Q000008:administration & dosage* / Q000009:adverse effects
D011453:Prostaglandins; D010121:Oxytocin